Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jan Presthus"'
Autor:
Jan Presthus
Publikováno v:
Acta Neurologica Scandinavica. 42:12-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7beec9eb141d5bbd994b361bfb17ed9
https://doi.org/10.1111/j.1600-0404.1966.tb01997.x
https://doi.org/10.1111/j.1600-0404.1966.tb01997.x
Autor:
Robert Holmsen, Jan Presthus
Publikováno v:
Acta Neurologica Scandinavica. 50:774-790
The efficacy of levodopa in long-term treatment has still not been sufficiently demonstrated. In this study 126 parkinsonians have been treated for a minimum of 12 and a maximum of 36 months. The patients were evaluated clinically at regular interval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d5d55ec2e3064f8ebc8cec6b2e7f5a6
https://doi.org/10.1111/j.1600-0404.1974.tb02818.x
https://doi.org/10.1111/j.1600-0404.1974.tb02818.x
Autor:
H. Pakkenberg, A Andersen, E Boisen, T N Kristensen, Jan Presthus, R Borgmann, Birgit Ohrt Mikkelsen, Erik Dupont, D Buch, J. Worm-Petersen, M O Kjaer, R Stien, J. Boas, A C Helgetveit
Publikováno v:
Acta Neurologica Scandinavica. 93:14-20
In this Danish-Norwegian randomized double-blind parallel-group multicentre study, we compared the therapeutic response of slow-release Madopar HBS® to standard Madopar® in 134 de novo patients with idiopathic Parkinson's disease during a 5-year pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7a06c4a542ffd9c671701d52f984d4a
https://doi.org/10.1111/j.1600-0404.1996.tb00163.x
https://doi.org/10.1111/j.1600-0404.1996.tb00163.x
Autor:
Jan Presthus, Ole‐Jørgen Julsrud
Publikováno v:
Acta Neurologica Scandinavica. 41:393-396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e885a66a8f0fe7dfba88c05f93617039
https://doi.org/10.1111/j.1600-0404.1965.tb01902.x
https://doi.org/10.1111/j.1600-0404.1965.tb01902.x
Autor:
Bent Egberg Mikkelsen, Johan A. Aarli, Jan Presthus, Birgit Ohrt Mikkelsen, Robert Holmsen, Eva Riman, Jette BØttcher, Birgit Severin, Jørgen Ankerhus, Rolf Nyberg-Hansen, Andrew Burén
Publikováno v:
Acta Neurologica Scandinavica. 58:77-79
An isoquinolone derivative Ro 8-4650 (rac-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-7-methoxy-2-methylisoquinoline hydrochloride) with dopaminergic properties was studied in a randomized crossover trial. The group studied comprised 37 patients with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb2baebc9184ad963a96c882bbe7893
https://doi.org/10.1111/j.1600-0404.1978.tb02863.x
https://doi.org/10.1111/j.1600-0404.1978.tb02863.x
Autor:
Birgit Ohrt Mikkelsen, Johan A. Aarli, Jette BØttcher, Eva Riman, Jan Presthus, Robert Holmsen, Bent Egberg Mikkelsen, Andrew Burén, Jørgen Ankerhus, Birgit Severin, Rolf Nyberg-Hansen
Publikováno v:
Acta Neurologica Scandinavica. 58:74-76
An isoquinoline derivative Ro 8–4650 (rac-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-7-methoxy-2-methylisoquinoline hydrochloride) with dopamin-ergic properties was studied in a randomized crossover trial. The group studied comprised 37 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c398387a96bac7db9cdcf71c69fe267a
https://doi.org/10.1111/j.1600-0404.1978.tb02862.x
https://doi.org/10.1111/j.1600-0404.1978.tb02862.x
Autor:
Ole‐Jergen Julsrud, Jan Presthus
Publikováno v:
Acta Neurologica Scandinavica. 41:433-434
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2aa9d94b19d26e5b027538b7eb5aa47
https://doi.org/10.1111/j.1600-0404.1965.tb01910.x
https://doi.org/10.1111/j.1600-0404.1965.tb01910.x
Autor:
Jan Presthus, Ole‐Jørgen Julsrud
Publikováno v:
Acta Neurologica Scandinavica. 43:123-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::058585dd5c899078da883d9158ceb1d2
https://doi.org/10.1111/j.1600-0404.1967.tb02080.x
https://doi.org/10.1111/j.1600-0404.1967.tb02080.x
Publikováno v:
European Neurology. 13:339-349
Twelve parkinsonian patients with an unsatisfactory therapeutic result on L-Dopa alone due to nausea, vomiting and involuntary movements were treated with L-Dopa and decarboxylase inhibitor. The daily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74c086316b69ef3ec49ec18e46049498
https://doi.org/10.1159/000114688
https://doi.org/10.1159/000114688
Autor:
Alajos Hajba, Jan Presthus
Publikováno v:
Acta Neurologica Scandinavica. 68:127-133
The purpose of this double-blind placebo controlled study was to estimate how much the levodopa dosage can be reduced, when deprenyl is used, without worsening the disease and to see whether deprenyl can reduce the "off-periods". The trial included 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9b427658c015f839a11bb1e6b91517
https://doi.org/10.1111/j.1600-0404.1983.tb01527.x
https://doi.org/10.1111/j.1600-0404.1983.tb01527.x